| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-09 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 8e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |